Navigation Links
Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Date:4/8/2011

rious medical conditions.  In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential treatment of gout, diseases of the eye (wet age-related macular degeneration and central retinal vein occlusion), and certain cancers.  Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis and other inflammatory conditions, pain, cholesterol reduction, allergic and immune conditions, and cancer.  Additional information about Regeneron and recent news releases are available on Regeneron's web site at www.regeneron.com.

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 16.913 billion (2010), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany.  The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions.  Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide.  Bayer HealthCare has a global workforce of 55.700 employees (Dec 31, 2010) and is represented in more than 100 countries.  Find more information at www.bayerhealthcare.com.

Regeneron Forward-Looking Statements

This news release includes forward-looking statements about Regeneron and its products, development programs, finances, and business, all of which involve a number of risks and uncertainties.  These include,
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
2. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
4. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
5. Regeneron Reports Third Quarter 2009 Financial and Operating Results
6. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
7. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
8. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
9. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
10. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
11. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015  An effective advisory ... provide non-binding but informed guidance to pharmaceutical organizations ... on investment, it is important for leaders to ... resources. Research and consulting leader ... assist pharmaceutical and medical device executives in identifying ...
(Date:5/1/2015)... LITTLE FALLS, N.J. , May 1, 2015 ... Andrew A. Krakauer , Chief Executive Officer, will be ... Conference at the Encore at the Wynn in ... for Thursday, May 14, 2015 at 10:00 AM PT/1:00 PM ... meetings during the day. An audio webcast ...
(Date:5/1/2015)... 2015   Heska Corporation (NASDAQ: HSKA ... of advanced veterinary diagnostic and other specialty veterinary products ... will present at the 16th Annual B. Riley & Co. ... The conference will be held May 12-14, 2015 at Lowes ... management will be available during the day on May 13 ...
Breaking Medicine Technology:New Study Presents Insights to Advisory Board Effectiveness in the Pharmaceutical Sector 2Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2
(Date:5/4/2015)... For partners who’d like to become ... Astroglide TTC™ (Trying to Conceive) . Unlike traditional ... levels, Astroglide TTC™ is specially formulated to provide a ... Centers for Disease Control, an average of one ... sustaining a pregnancy, and over 7.4 million women ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 “ Food Cost ... monthly AppWatch, which takes a look at the latest and ... Joe Toohey, the host of AppWatch and technology expert, conducted ... allows restaurant owners to manage and efficiently calculate food costs. ... country's economy. In fact, the industry has an estimated 1.8 ...
(Date:5/4/2015)... DC (PRWEB) May 04, 2015 ... has just released the first-ever congenital heart ... Cardiac Catheterization Laboratory (PCCL) accreditation. Driven by ... standards are a comprehensive review of interventional ... congenital heart disease. , “The ACE CHD ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 “St. Louis ... the “Gateway to the West,” so it is the ... Veterans Program”, says Dr. Ben Litalien, Chief Development Officer ... Association’s VetFran program and will provide veterans with a ... Zerorez® is proud to have a number of Military ...
(Date:5/4/2015)... Los Angeles, California (PRWEB) May 04, 2015 ... Inc., a physician practice management firm in Los ... (EECP®), announced today the patent-pending status of The Sara ... developed by Soulati in 2010, is a lifestyle modification ... submitted in April 2015 to the U. S. Patents ...
Breaking Medicine News(10 mins):Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 2Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 3Health News:An Application to Manage a Successful Restaurant Was Featured on NewsWatch Television 2Health News:Accreditation for Cardiovascular Excellence (ACE) Publishes New Standards for Pediatric and Adult Congenital Cardiac Catheterization Laboratories 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 3Health News:CEO Sara Soulati Announces Patent-Pending Designation For The Sara Soulati Health For Life Program 2
... ... a health care professional about different areas of vascular disease. Join us this Tuesday, ... from the Cleveland Clinic. Visit http://www.vdf.org/interactive/ask.php for log-in information. , ... Lakewood, CO (Vocus) April 5, ...
... Dermatologists using Vivacare,s ... help build awareness of this chronic skin condition and the importance of early diagnosis and ... (PRWEB) April 5, ... know it, but the public can now learn more about this chronic skin disorder from ...
... ... own dog food” as contributors collaborate virtually and document their experiences. , ... Emigsville, PA ... systems and data services, today announced their participation in the upcoming publication, Virtual ...
... ... Awareness Month after successful workshop at busy office shows internet entrepreneur stress-reducing benefits of guided ... (PRWEB) April ... tasks throughout the day, which can create a high level of stress. Being aware of ...
... Donate Life America, 43 percent of people are undecided, reluctant ... donated after their deaths. While an improvement over findings ... reported the same, the statistic illustrates a critical need to ... to save the lives of the more than 105,000 adults ...
... stares tempt you to give into your child,s meltdowns, expert ... what? , Parents often have a hard time figuring out ... It doesn,t help matters that kids often have their meltdowns ... restaurant. , Chuck Smith, a Kansas State University child development ...
Cached Medicine News:Health News:Live Online Chats Answer Questions About Vascular Disease 2Health News:Rosacea Awareness Month Honored by Dermatologists Using Vivacare to Deliver Rosacea Patient Education 2Health News:Vasont Systems Contributes Content Management Expertise to New Book on Virtual Collaborative Writing 2Health News:Vasont Systems Contributes Content Management Expertise to New Book on Virtual Collaborative Writing 3Health News:Guided Meditation Made Available to Everyone for Stress Awareness Month 2Health News:Number of Americans willing to donate organs rises, but still not keeping pace with need 2Health News:Number of Americans willing to donate organs rises, but still not keeping pace with need 3Health News:Dealing With Those All-Too-Public Tantrums 2
Delicate Desmarres lid retractors, round serrated handle, very thin blades, polished finish, size 1....
Size 4 - 2.25 mm...
... Catalyst system introduces a new ... to microsurgical instrumentation. It has ... design with advanced microcomputer control ... to operate with a full ...
... Horizon Phacoemulsification System is ... surgical system. Lightweight and ... performance and features in ... also provides all modes ...
Medicine Products: